Testosterone replacement for hypogonadism: clinical findings and best practices.
D045930:Anabolic Agents / Q000627:therapeutic use; D000728:Androgens / Q000627:therapeutic use; D019985:Benchmarking; D015992:Body Mass Index; D001835:Body Weight; D015519:Bone Density; D003866:Depressive Disorder / Q000517:prevention & control / Q000523:psychology / Q000821:virology; D005081:Exercise Therapy; D015658:HIV Infections / Q000150:complications*; D019247:HIV Wasting Syndrome / Q000523:psychology / Q000628:therapy*; D020249:Hormone Replacement Therapy / Q000379:methods* / Q000592:standards; D006801:Humans; D007006:Hypogonadism / Q000523:psychology / Q000628:therapy* / Q000821:virology*; D008297:Male; D010110:Oxymetholone / Q000627:therapeutic use; D011788:Quality of Life; D013739:Testosterone / Q000172:deficiency / Q000627:therapeutic use*; D016896:Treatment Outcome; D014891:Weight Lifting
D045930:Anabolic Agents; D000728:Androgens; D013739:Testosterone; D010110:Oxymetholone